Robust evidence for fenofibrate in patients with metabolic syndrome on statins
A nationwide population-based cohort study in South Korea compared the effectiveness of omega-3 fatty acids and fenofibrate for reducing major adverse cardiovascular events (MACE) in individuals with metabolic syndrome (≥30 years) on statin therapy.1

Hoạt chất mới

1 New

Chỉ định mới

4 New

Dạng hàm lượng mới

1 New

Ký hiệu trên viên thuốc
Hình dạng
Màu 1
Màu 2
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in